BIOGEN INC.
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
Chief Accounting Officer
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Chief Accounting Officer
Common Stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Chief Accounting Officer
Restricted Stock Unit
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Accounting Officer
Restricted Stock Unit
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Legal Officer
Restricted Stock Unit
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
Director
Common Stock
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Restricted Stock Unit
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Head of Corporate Development
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Head of Corporate Development
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Accounting Officer | Common StockOption exercise or conversion | 27$0 reported · see filing | Not established | Oct 2Filed Oct 5 · 3d later | SEC filing |
| Chief Accounting Officer | Common StockExercise-price or tax withholding | 8$219.88 / share | $1.76K | Oct 2Filed Oct 5 · 3d later | SEC filing |
| Chief Accounting Officer | Restricted Stock UnitGrant or award | Derivative units985Award · no purchase price | Non-cash award | Oct 1Filed Oct 5 · 4d later | SEC filing |
| Chief Accounting Officer | Restricted Stock UnitOption exercise or conversion | Derivative units27$0.00 exercise / conversion price | Not a separate purchase | Oct 2Filed Oct 5 · 3d later | SEC filing |
| Chief Legal Officer | Restricted Stock UnitGrant or award | Derivative units7,405Award · no purchase price | Non-cash award | Sep 1Filed Sep 3 · 2d later | SEC filing |
| Director | Common StockSale10b5-1 | 593$203.34 / share | $120.58K | Aug 3Filed Aug 5 · 2d later | SEC filing |
| Director | Common StockSale10b5-1 | 593$200.96 / share | $119.17K | Aug 4Filed Aug 5 · 1d later | SEC filing |
| Director | Common StockGrant or award | 1,505Award · no purchase price | Non-cash award | Jun 9Filed Jun 11 · 2d later | SEC filing |
| Director | Common StockGrant or award | 1,505Award · no purchase price | Non-cash award | Jun 9Filed Jun 11 · 2d later | SEC filing |
| Director | Common StockGrant or award | 1,505Award · no purchase price | Non-cash award | Jun 9Filed Jun 11 · 2d later | SEC filing |
| Director | Common StockGrant or award | 1,505Award · no purchase price | Non-cash award | Jun 9Filed Jun 11 · 2d later | SEC filing |
| Director | Common StockGrant or award | 1,505Award · no purchase price | Non-cash award | Jun 9Filed Jun 11 · 2d later | SEC filing |
| Director | Common StockGrant or award | 1,505Award · no purchase price | Non-cash award | Jun 9Filed Jun 11 · 2d later | SEC filing |
| Director | Common StockOption exercise or conversion | 2,370$0 reported · see filing | Not established | Jun 9Filed Jun 11 · 2d later | SEC filing |
| Director | Common StockGrant or award | 1,505Award · no purchase price | Non-cash award | Jun 9Filed Jun 11 · 2d later | SEC filing |
| Director | Restricted Stock UnitOption exercise or conversion | Derivative units2,370$0.00 exercise / conversion price | Not a separate purchase | Jun 9Filed Jun 11 · 2d later | SEC filing |
| Director | Common StockGrant or award | 1,505Award · no purchase price | Non-cash award | Jun 9Filed Jun 11 · 2d later | SEC filing |
| Director | Common StockGrant or award | 2,005Award · no purchase price | Non-cash award | Jun 9Filed Jun 11 · 2d later | SEC filing |
| Head of Corporate Development | Common StockOption exercise or conversion | 939$0 reported · see filing | Not established | May 1Filed May 5 · 4d later | SEC filing |
| Head of Corporate Development | Common StockExercise-price or tax withholding | 455$187.06 / share | $85.11K | May 1Filed May 5 · 4d later | SEC filing |
Showing the latest 20 of 24 trades. Show all 24 trades
Biogen Inc. - Common Stock (BIIB) · Stock
The filing reports a sale for the member.
Kevin HernReporting House memberBiogen Inc. - Common Stock · Stock
The filing reports a purchase for the member.
Biogen Inc. - Common Stock (BIIB) · Stock
The filing reports a sale for the member.
Maria Elvira SalazarReporting House memberBiogen Inc. - Common Stock (BIIB) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberBiogen Inc. - Common Stock (BIIB) · Stock
The filing reports a purchase for the member.
Maria Elvira SalazarReporting House memberBiogen Inc. - Common Stock (BIIB) · Stock
The filing reports a purchase for the member.
Maria Elvira SalazarReporting House memberBiogen Inc. - Common Stock (BIIB) · Stock
The filing reports a purchase for the member.
Maria Elvira SalazarReporting House memberBiogen Inc. - Common Stock (BIIB) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House member